« Previous
Next »
American Journal of Obstetrics & Gynecology
Volume 197, Issue 4
, Pages 337-339
, October 2007
The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination
References
- . Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
- . Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer. 2004;109:418–424
- Cancer Facts and Figures 2007. American Cancer Society; 2007;
- . Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics. 2005;23:1107–1122
- . Vaccines against human papillomavirus and cervical cancer: promises and challenges. Oncologist. 2005;10:528–538
- . Human papillomavirus vaccine: a new chance to prevent cervical cancer. Recent Results Cancer Res. 2007;174:81–90
- The 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346–355
- The 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in-situ. Am J Obstet Gynecol. 2007;197:340–345
- . Cervical cancer screening. Curr Oncol Rep. 2004;6:497–506
- . Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination. Future Oncol. 2007;3:319–327
- . Will widespread human papillomavirus prophylactic vaccination change sexual practices of adolescent and young adult women in America?. Obstet Gynecol. 2006;108:420–424
PII: S0002-9378(07)00996-9
doi: 10.1016/j.ajog.2007.08.030
© 2007 Mosby, Inc. All rights reserved.
« Previous
Next »
American Journal of Obstetrics & Gynecology
Volume 197, Issue 4
, Pages 337-339
, October 2007
